trial · primary record
BI 764532
Small Cell Lung Carcinoma (SCLC)
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 46 |
| Primary completion | 2027-04-01 |
| Primary endpoint | Part A - Dose escalation: Occurrence of dose limiting toxicities (DLTs) in the maximum tolerated dose (MTD) evaluation period |
| Registry ID | NCT06077500 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:48.861Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06077500
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.